VFlutter
Flight Nurse
- 3,728
- 1,265
- 113
For those that do ECMO transports, are you seeing an increase in VA ECMO + Impella aka ECPELLA? This seems to becoming a more popular treatment.
One of the biggest problems with VA ECMO is the significantly increased afterload, from retrograde arterial flow, resulting in increased LV wall tension and dilation. Not a huge deal if the ECMO is used as a bridge to device, LVAD, however if the goal is native heart recovery then it needs to be addressed by "venting" the LV. The two most popular options are IABP or Impella. The benefit of IABP are significantly reduced cost and relative simplicity compared to the Impella however the Impella seems to be the most effective.
In practice you will see a VA ECMO patient with an Impella on p1 or p2 providing just enough flow (~ 1 Lpm) to offload the LV. It will likely be alarming due to inability to obtain a placement signal. The patient will be extremely volume dependent and is a constant balancing act between the ECMO, Impella, and native heart flows.
Overall, pretty cool.
https://www.jhltonline.org/article/S1053-2498(16)00970-0/abstract
One of the biggest problems with VA ECMO is the significantly increased afterload, from retrograde arterial flow, resulting in increased LV wall tension and dilation. Not a huge deal if the ECMO is used as a bridge to device, LVAD, however if the goal is native heart recovery then it needs to be addressed by "venting" the LV. The two most popular options are IABP or Impella. The benefit of IABP are significantly reduced cost and relative simplicity compared to the Impella however the Impella seems to be the most effective.
In practice you will see a VA ECMO patient with an Impella on p1 or p2 providing just enough flow (~ 1 Lpm) to offload the LV. It will likely be alarming due to inability to obtain a placement signal. The patient will be extremely volume dependent and is a constant balancing act between the ECMO, Impella, and native heart flows.
Overall, pretty cool.
https://www.jhltonline.org/article/S1053-2498(16)00970-0/abstract